SCIRENT will be participating in the renowned ESC Congress in Amsterdam from 25th to 28th August 2023. This prestigious event is a powerful platform for us as it brings together leading experts from the field of cardiology to shape the future of this field.
ESC Congress is the place where cardiologists and researchers of all stages of their career join forces with colleagues, peers, and their cardiology heroes, to share invaluable data and learn. Attending the ESC Congress will provide you with a unique opportunity to expand your network, gain fresh perspectives, and foster synergies with experts and professionals from around the world.
The spotlight of ESC Congress 2023 will be heart failure. Many of the problems cardiovascular professionals deal with are either the cause or complications of heart failure, including coronary artery disease, valvular problems, stroke, arrhythmias and sudden death. Heart failure is relevant to all areas of cardiology and beyond, including obesity, diabetes, and chronic kidney disease, making it a relevant spotlight for ESC Congress 2023.
As a leader in the field of clinical research in cardiovascular medicine, SCIRENT is eager to connect with the global cardiology community at the ESC Congress, including European-based investigators interested in participating in clinical trials, as well as our existing clients and prospective sponsors. With our industry-leading CRO model, we want to contribute to positive development outcomes in clinical trials in cardiology.
Whether you are able to join us in Amsterdam or participate online, we invite you to connect with us and make a difference. No matter where you are in the world or what role you play in supporting patients facing cardiovascular disease, your presence and contribution matter greatly.
At ESC Congress 2023 we will be ‘joining forces to protect the heart’ and create the future of cardiology. Stay tuned for further updates on our participation at ESC Congress 2023, as we work together to advance the field of cardiology and improve patient outcomes.